BackOncology Pharma Overview

Oncology Pharma Long Term Debt

Explore Oncology Pharma's long-term debt with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
N/A

Peer trimmed avg / median

Loading

Oncology Pharma Long Term Debt History

Loading

Oncology Pharma vs. peers: Long Term Debt Comparison

Loading

Oncology Pharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Oncology Pharma (ONPH) FAQ

Stockcircle tracks long-term debt for Oncology Pharma (ONPH), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Long-Term Debt page is built for Oncology Pharma's historical long-term debt trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use long-term debt as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main ONPH overview so you can move from this figure to the surrounding analysis quickly.